Skip to content
Home/Companies/Healthcare/BIOGEMMA
BI

BIOGEMMA

Healthcare·France·Exited 2018·Held 2yr

BIOGEMMA is a healthcare company, headquartered in France.

Entry
2016
Hold
2yr
Exit
2018
Est. EV
–

Who owns BIOGEMMA?

BIOGEMMA was owned by Unigrains through Unigrains Capital Investissement Direct (2010 vintage) from 2016 to 2018, exited via MBO.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Unigrains
Investor
Unigrains
Unigrains Capital Investissement Direct · 2010 · Buyout

Key facts

HQFrance
SectorHealthcare
Exit Type
MBO
Buyer
MOIC
–
Exit Year
2018

More from Unigrains Capital Investissement Direct

Other portfolio companies in the same fund.

IRRIFRANCE Groupe
Active
· 2025
L'Albero del Pane
Active
· 2025
LIM Group
Active
IndustrialsFrance· 2025
SICAVYL SICA DE VIANDES DE L YONNE ET DU LOIRET
Active
Business ServicesFrance· 2025
Staphyt
Active
· 2025
Demarne
Active
ConsumerFrance· 2024

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings